Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists.
about
Gamma Knife radiosurgery for medically and surgically refractory prolactinomas: long-term results.Gamma knife radiosurgery for medically and surgically refractory prolactinomas.Retrospective Analysis of Cushing's Disease with or without HyperprolactinemiaClinical course of hyperprolactinemia in children and adolescents: a review of 21 cases.Effect of dopaminergic drug treatment on surgical findings in prolactinomas.Treatment of hyperprolactinemia: a systematic review and meta-analysis.The utility of high-resolution intraoperative MRI in endoscopic transsphenoidal surgery for pituitary macroadenomas: early experience in the Advanced Multimodality Image Guided Operating suite.Pharmacotherapy for adults with tumors of the central nervous system.Long-Term Clinical Outcomes of Invasive Giant Prolactinomas after a Mean Ten-Year Followup.Dopamine agonists in the treatment of prolactinoma: are they still first choice?Resistant prolactinomas.Current treatment options for hyperprolactinemia.Management of medically refractory prolactinoma.Preoperative Stratification of Transsphenoidal Pituitary Surgery Patients Based on Surgical Urgency.Prolactinomas in children under 14. Clinical presentation and long-term follow-up.Medically treated prolactin-secreting pituitary adenomas: when should we operate?Diagnosis and treatment of pituitary microadenoma: report of 80 cases.Surgical treatment of prolactinomas: cons.The Chance of Permanent Cure for Micro- and Macroprolactinomas, Medication or Surgery? A Systematic Review and Meta-Analysis
P2860
Q30299965-BC740F17-F01C-46E8-9751-F843DCB0A611Q30441161-5848CAD4-BBD4-498E-94CF-62AD43F5C7A6Q34652203-74AB490C-2C4C-4247-8110-3C6710B019D7Q35058041-90AF69AF-3230-4BDA-9BEA-8283F258384CQ36182003-579BA740-E9F9-415D-87C9-FAE13225F7A7Q36355322-C8F393DC-FC52-46CA-87DC-1F1DB69A197CQ37193398-258028F2-3E57-4226-9EDD-58709DC83ED8Q37353276-A92E7A42-FD28-48EA-9563-C87C99032F18Q37480022-579B8DA5-2441-4C77-95FC-B9A7925F783FQ37817505-592D6934-84AE-4191-BC39-BC5F65D52661Q37853323-ACA0FAF0-5C27-4D8D-8272-FF65A4BDEE9CQ38112205-B4A97A6B-1940-40A0-A1FE-B60A88D9E311Q38154516-53085C1B-840C-4CAF-925F-F7B0B43C4AF9Q38682306-DD58479D-B336-4F48-9392-730F82AA3F8CQ41221512-8B5EBC6F-E278-4DDD-9D8C-832F8F696818Q44195590-19701F8F-294D-4BE5-9994-613895AC5853Q46468732-945C2919-C5E7-405C-A3F2-E8B9A2D44825Q47833165-0781CB57-DA75-4267-933C-FB173551BF57Q58556107-F376D981-9C72-4D4A-9458-F79D3D378253
P2860
Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Surgical outcomes in hyporespo ...... olerance to dopamine agonists.
@ast
Surgical outcomes in hyporespo ...... olerance to dopamine agonists.
@en
type
label
Surgical outcomes in hyporespo ...... olerance to dopamine agonists.
@ast
Surgical outcomes in hyporespo ...... olerance to dopamine agonists.
@en
prefLabel
Surgical outcomes in hyporespo ...... olerance to dopamine agonists.
@ast
Surgical outcomes in hyporespo ...... olerance to dopamine agonists.
@en
P2093
P1433
P1476
Surgical outcomes in hyporespo ...... olerance to dopamine agonists.
@en
P2093
D Kojo Hamilton
Edward R Laws
Mary Lee Vance
Paul T Boulos
P2888
P356
10.1007/S11102-005-5086-1
P577
2005-01-01T00:00:00Z